Document:

Exhibit 10.13

 

ESCROW AGREEMENT

 

THIS AGREEMENT (this “Agreement”)
is made this May [    ], 2021 by and among EZGO Technologies Ltd., a British Virgin Islands company (the “Issuer”), FT Global
Capital, Inc., the “Placement Agent”) whose name and address appear on the Information Sheet (as defined herein) attached
to this Agreement and Continental Stock Transfer & Trust Company, 1 State Street, 30th Floor, New York, New York 10004 (the “Escrow
Agent”). Capitalized term used herein and not otherwise defined herein shall have the respective meaning set forth in the Placement
Agency Agreement (as defined below).

 

W I T N E S S E T H:

 

WHEREAS, the Issuer
has filed with the Securities and Exchange Commission (the “Commission”) a Registration Statement, as amended (the “Registration
Statement”) covering the proposed initial public offering of its ordinary shares (the “Securities”);

 

WHEREAS, the Placement
Agent proposes, pursuant to the terms of the Registration Statement and that certain Placement Agency Agreement, dated as of May [ ],
2021, by and between the Placement Agent, as representative of the Placement Agents named therein, and the Issuer (the “Placement
Agency Agreement”) to offer the Securities, as agent for the Issuer, for sale in a public offering of the Company’s securities
to the public on a “best-efforts” basis without a firm commitment by the Placement Agent (the “Offering”);

 

WHEREAS, the Registration
Statement contemplates the execution and delivery of this Agreement and the deposit by Issuer with the Escrow Agent of $[ ] (the “Escrow
Amount”) in order to provide source of funding for certain indemnification obligations of Issuer as described in the Registration
Statement and the Placement Agency Agreement, and the parties hereto wish such deposit to be subject to the terms and conditions set forth
herein and in the Placement Agency Agreement; and

 

WHEREAS, the Issuer
and the Placement Agent propose to establish an escrow account (the “Escrow Account”), to which the Escrow Amount is be credited,
and the Escrow Agent is willing to establish the Escrow Account and the terms thereof are subject to the conditions hereinafter set forth.

 

NOW, THEREFORE in consideration of the
premises and mutual covenants herein contained, the parties hereto hereby agree as follows:

 

	1.	Information Sheet. Each capitalized term not otherwise defined in this Agreement shall have
the meaning set forth for such term on the information sheet which is attached to this Agreement as Exhibit A and is incorporated
by reference herein and made a pact hereof (the “Information Sheet”).

 

    -1-

     

    

 

	2.	Establishment of the Bank Account.

 

2.1 The
Escrow Agent shall establish an interest bearing bank account  at the branch of [ ] (the “Bank”)
selected by the Escrow Agent, and bearing the designation set forth on the Information Sheet (heretofore defined as the “Bank Account”).
While the funds are on deposit, the Escrow Agent may earn bank credits or other consideration. The purpose of the Bank Account is for
(a) the deposit of the Escrow Amount by the Issuer to the Escrow Agent, (b) the holding of the Escrow Amount and (c) the disbursement
of the Escrow Amount, all as described herein.

 

	3.	Deposits to the Bank Account.

 

3.1 The Issuer shall, upon
the closing of the Offering, deliver to the Escrow Agent, by wire transfer in accordance with the wire transfer instructions set forth
on the Information Sheet, the Escrow Amount. Upon the Escrow Agent’s receipt of the Escrow Amount, it shall be credited to the Escrow
Account.

 

3.2 Promptly after receiving
the Escrow Amount as described in Section 3.1, the Escrow Agent shall deposit the same into the Bank Account. The Escrow Agent shall cause
the Bank to process the Escrow Amount for collection through the banking system.

 

	4.	Disbursement from the Bank Account.

 

4.1 Promptly following the
date that is six (6) months after the closing date of the Offering (the “Closing Date”), the Escrow Agent shall retain in
the Escrow Account such amount that is the subject of all claim notices, if any, delivered by the Placement Agent to the Issuer in connection
with the Company’s indemnification obligations in accordance with the Placement Agency Agreement, and shall pay the remaining balance
of the Escrow Account, if any, to the Issuer (subject to withholding as applicable) based on a release instruction issued jointly by the
Issuer and the Placement Agent (the “Joint Release Instruction”).

 

4.2 In the event that the
Placement Agent delivers a claim notice in accordance with the Placement Agency Agreement on or prior to the day that is that is six (6)
months after the Closing Date, as applicable, the Escrow Agent shall continue to hold in escrow and shall not release, an amount of funds
then held in escrow equal to the lesser of: (i) the amount claimed by the Placement Agent which is payable to the Placement Agent in accordance
with the terms of the Placement Agency Agreement (but not in any event in excess of the Escrow Amount); or (ii) the balance of the Escrow
Account which is available for release and distribution to the Issuer. The portion of the Escrow Account in excess of the amount specified
in clause (i) of the preceding sentence (as may be the subject of one or more timely delivered claim notices) shall be released by the
Escrow Agent as specified in Section 4.1 (as may be applicable). With respect to the amounts specified in any such timely delivered claim
notices, the Escrow Agent shall promptly disburse funds from the Escrow Account within three (3) Business Days (as defined herein) after
delivery to the Escrow Agent of: (i) a Joint Release Instruction, as may be directed in such Joint Release Instruction; or (ii) if the
Placement Agent and the Issuer are unable for any reason to issue a Joint Release Instruction (including in any case in which the Placement
Agent and the Issuer are unable to agree on the terms of a Joint Release Instructions), within ten (10) Business Days following the request
of a party to issue such Joint Release Instruction, as specified in the terms of a Final Determination (as defined herein).

 

    -2-

     

    

 

4.3 For purposes of this Agreement:
(a) “Business Day” means any day that is not a Saturday, a Sunday or other day on which commercial banks located in New York,
New York, are obligated or authorized by applicable law to remain closed for business; provided, however, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home,” “shelter-in-place,”
“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day; and (b) “Final Determination” means a final
non-appealable order of any court of competent jurisdiction which may be issued, together with (A) a certificate of the prevailing party
to the effect that such judgment is final and non-appealable and from a court of competent jurisdiction having proper authority and (B)
the written payment instructions of the prevailing party.

 

4.4 Upon disbursement of the
Escrow Amount pursuant to the terms of this Article 4, the Escrow Agent shall be relieved of all further obligations and released from
all liability under this Agreement. It is expressly agreed and understood that in no event shall the aggregate amount of payments made
by the Escrow Agent exceed the amount of the Escrow Amount.

 

	5.	Rights, Duties and Responsibilities of Escrow Agent. It is understood and agreed that the
duties of the Escrow Agent are purely ministerial in nature, and that:

 

5.1 The Escrow Agent shall
not be responsible for or be required to enforce any of the terms or conditions of the Placement Agency Agreement or any other agreement
between the Placement Agent and the Issuer nor shall the Escrow Agent be responsible for the performance by the Placement Agent or the
Issuer of their respective obligations under this Agreement.

 

5.2 The Escrow Agent shall
be entitled to rely upon the accuracy, act in reliance upon the contents, and assume the genuineness of any notice, instruction, certificate,
signature, instrument or other document which is given to the Escrow Agent pursuant to this Agreement without the necessity of the Escrow
Agent verifying the truth or accuracy thereof. The Escrow Agent shall not be obligated to make any inquiry as to the authority, capacity,
existence or identity or any person purporting to give any such notice or instructions or to execute any such certificate, instrument
or other document.

 

5.3 If the Escrow Agent is
uncertain as to its duties or rights hereunder or shall receive instructions with respect to the Bank Account, the Escrow Amount which,
in its sole determination, are in conflict either with other, instructions received by it or with any provision of this Agreement, it
shall be entitled to hold the Escrow Amount or a portion thereof, in the Bank Account pending the resolution of such uncertainty to the
Escrow Agent’s sole satisfaction, by final judgment of a court or courts of competent jurisdiction or otherwise; or the Escrow Agent,
at its sole option, may deposit the Escrow Amount with the Clerk of a court of competent jurisdiction in a proceeding to which all parties
in interest are joined. Upon the deposit by the Escrow Agent of the Escrow Amount with the Clerk of any court, the Escrow Agent shall
be relieved of all further obligations and released from all liability hereunder.

 

    -3-

     

    

 

5.4 The Escrow Agent shall
not be liable for any action taken or omitted hereunder, or for the misconduct of any employee, agent or attorney appointed by it, except
in the case of willful misconduct or negligence. The Escrow Agent shall be entitled to consult with counsel of its own choosing.

 

5.5 The Escrow Agent shall
have no responsibility at any time to ascertain whether or not any security interest exists in the Escrow Amount or any part thereof or
to file any statement under the Uniform Commercial Code with respect to the Escrow Amount or any part thereof.

 

	6.	Amendment; Resignation.

 

 6.1 This Agreement may
be altered or amended only with the written consent of the Issuer, the Placement Agent and the Escrow Agent.

 

6.2 The Escrow Agent may resign
for any reason upon thirty (30) business days’ written notice to the Issuer and the Placement Agent. Should the Escrow Agent resign
as herein provided, it shall not be required to make any disbursement or otherwise dispose of the Escrow Amount, but its only duty shall
be to hold the Escrow Amount until they clear the banking system for a period of not more than five (5) Business Days following the effective
date of such resignation, at which time (a) if a successor escrow agent shall have been appointed and written notice thereof (including
the name and address of such successor escrow agent) shall have been given to the resigning Escrow Agent by the Issuer, the Placement
Agent and such successor escrow agent, then the resigning Escrow Agent shall pay over to the successor escrow agent the Escrow Amount,
less any portion thereof previously paid out in accordance with this Agreement; or (b) if the resigning Escrow Agent shall not have received
written notice signed by the Issuer, the Placement Agent and a successor escrow agent, then the resigning Escrow Agent shall promptly
deposit the Escrow Amount with the Clerk of a court of competent jurisdiction in a proceeding to which all parties in interest are joined.
Upon the deposit by the Escrow Agent of the Escrow Amount with the Clerk of any court, the Escrow Agent shall be relieved of all further
obligations and released from all liability hereunder. Without limiting the provisions of Section 8 hereof, the resigning Escrow Agent
shall be entitled to be reimbursed by the Issuer and the Placement Agent for any actual and reasonable expenses incurred in connection
with its resignation, transfer of the Escrow Amount to a successor escrow agent or distribution of the Escrow Amount pursuant to this
Section 6.

 

	7.	Representations and Warranties. The Issuer and the Placement Agent hereby jointly and severally
represent and warrant to the Escrow Agent that:

 

7.1 No party other than the
parties hereto have, or shall have, any lien, claim or security interest in the Escrow Amounts or the Fund or any part thereof.

 

7.2 No financing statement
under the Uniform Commercial Code is on file in any jurisdiction claiming a security interest in or describing (whether specifically or
generally) the Escrow Amount or any part thereof.

 

    -4-

     

    

 

7.3 Reasonable controls have
been established and required due diligence performed to comply with “Know Your Customer” regulations, USA Patriot Act, Office
of the Foreign Asset Control (OFAC) regulations and the Bank Secrecy Act.

 

	8.	Fees and Expenses. The Escrow Agent shall be entitled to the Escrow Agent Fees set forth
on the Information Sheet, payable as and when stated therein. In addition, the Issuer and the Placement Agent jointly and severally agree
to reimburse the Escrow Agent for any reasonable expenses incurred in connection with this Agreement, including, but not limited to, reasonable
counsel fees. Upon receipt of the Escrow Amount, the Escrow Agent shall have a lien thereupon to the extent of its fees for services as
Escrow Agent.

 

	9.	Indemnification and Contribution.

 

9.1 The Issuer and the Placement
Agent (collectively referred to as the “Indemnitors”) jointly and severally agree to indemnify the Escrow Agent and its officers,
directors, employees, agents and shareholders (collectively referred to as the “Indemnitees”) against, and hold them harmless
of and from, any and all loss, liability, cost, damage and expense, including, without limitation, reasonable counsel fees, which the
Indemnitees may suffer or incur by reason of any action, claim or proceeding brought by a third party against the Indemnitees arising
out of or relating in any way to this Agreement or any transaction to which this Agreement relates, unless such action, claim or proceeding
is the result of the willful misconduct or gross negligence of the Indemnitees.

 

9.2 If the indemnification
provided for in Section 9.1 is applicable, but for any reason is held to be unavailable, the Indemnitors shall contribute such amounts
as are just and equitable to pay, or to reimburse the Indemnitees for, the aggregate of any and all losses, liabilities, costs, damages
and expenses, including counsel fees, actually incurred by the Indemnitees as a result of or in connection with, and any amount paid in
settlement of, any action, claim or proceeding arising out of or relating in any way to any actions or omissions of the Indemnitors.

 

9.3 The provisions of this
Article 9 shall survive any termination of this Agreement, whether by disbursement of the Escrow Amount, resignation of the Escrow Agent
or otherwise.

 

	10.	Governing Law and Assignment. This Agreement shall be construed in accordance with and governed
by the laws of the State of New York and shall be binding upon the parties hereto and their respective successors and assigns; provided,
however, that any assignment or transfer by any party of its rights under this Agreement or with respect to the Escrow Amounts shall be
void as against the Escrow Agent unless (a) written notice thereof shall be given to the Escrow Agent; and (b) the Escrow Agent shall
have consented in writing to such assignment or transfer.

 

    -5-

     

    

 

	11.	Notices. All notices, demands, consents, requests, instructions and other communications
to be given or delivered or permitted under or by reason of the provisions of this Agreement or in connection with the transactions contemplated
hereby shall be in writing and shall be deemed to be delivered and received by the intended recipient as follows: (i) if personally delivered,
on the business day of such delivery (as evidenced by the receipt of the personal delivery service), (ii) if mailed certified or registered
mail return receipt requested, on the business day of such delivery (as evidenced by the signed certified mail card), (iii) if delivered
by overnight courier (with all charges having been prepaid), on the business day of such delivery (as evidenced by the receipt of the
overnight courier service of recognized standing), (iv) if delivered by facsimile transmission, on the business day of such delivery if
sent by 6:00 p.m. in the time zone of the recipient, or if sent after that time, on the next succeeding business day (as evidenced by
the printed confirmation of delivery generated by the sending party’s telecopier machine), or (v) if delivered by email on the business
day of such delivery (as evidenced by delivery confirmation). If any notice, demand, consent, request, instruction or other communication
cannot be delivered because of a changed address of which no notice was given (in accordance with this Section 11), or the refusal to
accept same, the notice, demand, consent, request, instruction or other communication shall be deemed received on the second business
day the notice is sent (as evidenced by a sworn affidavit of the sender). All such notices, demands, consents, requests, instructions
and other communications will be sent to addresses or facsimile numbers as applicable set forth hereunder.

 

If to the Company, to:

 

EZGO Technologies,
Ltd.

Building #A, Floor 2, Changzhou Institute
of Dalian University of Technology,

Science and Education Town

Wujin District, Changzhou City

Jiangsu, China 213164

Attention: Jianhui Ye, Chief Executive Officer

Email:

 

with a copy to (which shall not constitute
notice):

 

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas

New York, New York 10105

Attention: Richard I. Anslow, Esq.

Email: Ranslow@egsllp.com

Facsimile:

 

If to the Placement
Agent, to:

 

FT Global Capital,
Inc.

________________

________________

Attention: Patrick
Ko

Email: pko@ftgobalcap.com

 

    -6-

     

    

 

with a copy
to (which shall not constitute notice):

 

Sheppard, Mullin,
Richter & Hampton LLP

30 Rockefeller
Plaza

New York, NY 10112

Attention: Richard
A. Friedman, Esq.

Email: rafriedman@sheppardmullin.com

Facsimile: 212-653-8701

 

If to the Escrow
Agent, to:

 

Continental Stock
Transfer & Trust Company

1 State Street, 30th Floor

New York, New York 10004

Attention: Jaswinder Goraya

Email: jgoraya@continentalstock.com

Facsimile: 212-616-7620

 

	12.	Severability. If any provision of this Agreement or the application thereof to any person
or circumstance shall be determined to be invalid or unenforceable, the remaining provisions of this Agreement or the application of such
provision to persons or circumstances other than those to which it is held invalid or unenforceable shall not be affected thereby and
shall be valid and enforceable to the fullest extent permitted by law.

 

	13.	Execution in Several Counterparts. This Agreement may be executed in several counterparts or by
separate instruments, and all of such counterparts and instruments shall constitute one agreement, binding on all of the parties hereto.

 

	14.	Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with
respect to the subject matter hereof and supersedes all prior agreements and understandings (written or oral) of the parties in connection
therewith.

 

[Signature Page Follows]

 

    -7-

     

    

 

IN WITNESS WHEREOF, the undersigned have executed
this Agreement as of the day and year first above written.

 

	THE ISSUER	 
	 	 	 	 
	By: 	 	 
	 	Name: 	Jianhui Ye	 
	 	Title:	Chief Executive Officer	 
	 	 	 	 
	THE PLACEMENT AGENT	 
	 	 	 	 
	By: 	 	 
	 	Name:	 	 
	 	Title:	 	 
	 	 	 	 
	CONTINENTAL STOCK TRANSFER & TRUST COMPANY	 
	 	 	 	 
	By: 	 	 
	 	Name:	 	 
	 	Title:	 	 

 

[Signature Page to Escrow Agreement]

 

     

     

    

 

EXHIBIT A

 

ESCROW AGREEMENT INFORMATION SHEET

 

1. The Issuer

 

Name: EZGO Technologies, Ltd.

 

Address:

 

Building #A, Floor 2, Changzhou Institute
of Dalian University of Technology,

Science and Education Town

Wujin District, Changzhou City

Jiangsu, China 213164

 

2. The Placement
Agent

 

Name: FT Global Capital, Inc.,
as the Placement Agents

 

Address:

 

3. Title of Escrow Account

 

“CST&T as agent for EZGO Technologies.,
Ltd. and FT Global Capital, Inc.”

 

4. Escrow Agent Fees and Charges

 

	Administration & Agency Fee	$[6,500.00]

 

The acceptance fee and administration fee covers all account set-up
services, the review, negotiation and execution of the litigation fund deposit agreement, KYC, OFAC and USA Patriot Act due diligence,
claim instructions and release instructions, on-going account, compliance review, records retention, enclosing and mailing Forms 1099
B and escheat services The escrow agent acceptance fee and administration fee is due and payable upon the effective date of appointment.
See assumptions for duration.

 

	Claims Processed, per claim	$[750.00]

 

	Out-of-pocket expenses	At cost

 

Out-of-pocket expenses when applicable will be
billed at cost at the sole discretion of Continental Stock Transfer & Trust Company.

 

     

     

    

 

	Extraordinary services	Market rate

 

Fees for services not specifically covered in
this schedule will be billed in accordance with our prevailing rates for such services.

 

These costs may include, but are not limited
to, review of IRS Form W-8IMY for foreign holders, shareholder presentment status updates, shareholder record adjustments, electronic
copies of shareholder presentments and non-standard shareholder records.

 

Assumptions

 

This proposal is based upon the following assumptions
with respect to the role of administrative agent. Should any of the assumptions, duties or responsibilities change, we reserve the right
to affirm, modify or rescind this proposal.

 

		●	The period of this Engagement Letter is 6 months. Beyond this duration, a fee of $[400.00]/month will
be in effect.

 

		●	Continental will be provided W-9/appropriate W-8 forms and payment instructions for disbursements.

 

Terms and conditions

 

Invoices outstanding for over 30 days are subject
to a 1.5% per month late payment penalty.

 

5. Escrow
Agent Wire Transfer Instructions

 

Account Name: 

Continental Stock Transfer & Trust Company as Agent for EZGO
Technologies, Ltd. Escrow 2021

 

	Short name: 	CST&T AAF EZGO Technologies, Ltd. Escrow 2021
	 	 
	[Address:	1 State Street, 30th Floor
	 	New York, NY 10004
	BANK:	JPMorgan Chase Bank, N.A.
	 	4 NYP, Floor 15
	 	New York, NY 10004
	ACCOUNT #:	 
	ABA #:	021000021
	SWIFT CODE:	CHASUS33
	Reference:	Attn:  Patrick Small ]

 

	PRIMARY CONTACT: 	 	SECONDARY CONTACT: 
	Patrick Small 	 	Jaswinder Goraya
	SPAC & Escrow Administrator 	 	Corporate Actions Administration
	Continental Stock Transfer & Trust Company 	 	Continental Stock Transfer & Trust Company
	Accounting Department 	 	Corporate Actions Services 
	1 State Street, 30th Floor	 	1 State Street, 30th Floor
	New York, NY 10004 	 	New York, NY 10004 
	0: (212) 845-5284	 	0: (212)-845-5212   
	F: (212) 616-7620	 	E:  jgoraya@continentalstock.com
	E:  psmall@continentalstock.comExhibit 10.1

  

  

    SHARE REPURCHASE AGREEMENT

    THIS SHARE REPURCHASE AGREEMENT (this "Agreement") is made and entered into as of May 20, 2021, by and between Innoviva, Inc., a Delaware corporation ("Company"),

      and Glaxo Group Limited, a private company limited by shares registered under the laws of England and Wales ("Seller").

    1. Purchase and Sale of Shares.

    (a) Purchase and Sale. Upon the terms set forth in this Agreement, effective as of the Closing, the Company hereby purchases from the Seller, and the Seller hereby sells to the Company, 32,005,260 shares

        of common stock of the Company, par value $0.01 per share, owned by Seller (the "Shares"), representing all of the shares of common stock or other capital interests of the Company owned beneficially or of record by GlaxoSmithKline plc, the
        ultimate parent company of Seller (“GSK”), or its controlled affiliates (excluding any securities held by any employee benefit plan or similar plan or entity), at a price per Share of $12.25, representing aggregate consideration for all such
        Shares of $392,064,435 (the “Closing Consideration”).

    2. Settlement.  The closing of the purchase by the Company and sale by the Seller of the Shares (the “Closing”) shall be held on May 25, 2021, or on such other date and time as the Company and Seller agree (the "Closing Date").

        On the Closing Date, (i) the Company shall pay the Closing Consideration for all of the Shares purchased and sold hereunder by wire transfer of immediately available funds to such account as the Seller shall have specified in writing and (ii) the
        Company and the Seller shall cause the Shares to be transferred to the Company's account at the Company's transfer agent and the Seller shall deliver appropriate stock transfer powers representing the Shares in customary form.  On or promptly after
        the Closing Date, the Seller shall deliver the stock certificates representing the Shares  or customary lost stock affidavits in lieu thereof.  The obligations of the parties to consummate the Closing shall be conditioned only on there being, as of
        the Closing Date, no injunctions, orders or other restraints issued by a governmental authority with competent jurisdiction restraining or prohibiting the consummation of the Closing and the delivery by the Seller of the Shares free and clear of
        any liens, encumbrances, or charges, of any kind (other than any lien, encumbrance or charge arising as a result of the Company’s purchase or ownership of any such Shares or which arise under applicable federal and state securities laws).

    3. Representations and Warranties of Seller.  The Seller represents and warrants to the Company as of the date hereof and as of the Closing Date as follows:

    (a) The Seller owns all of the Shares. No person or entity has asserted in writing any claim or commenced or threatened any litigation concerning the Seller's title to the Shares. Upon delivery of the Shares, the Seller will convey to Company
        valid title to the Seller's Shares, free and clear of any liens, encumbrances, or charges, of any kind (other than any lien, encumbrance or charge arising as a result of the Company’s purchase or ownership of any such Shares or which arise under
        applicable federal and state securities laws);

    (b) Other than as set forth in this Agreement and as is being sold to the Company hereunder, GSK and its controlled affiliates (excluding any securities held by any employee benefit plan or similar plan or entity) do not own, beneficially or of
        record, any shares of capital stock or other equity interests in the Company;

    (c) The Seller is a private company limited by shares registered under the laws of England and Wales and is duly organized and validly existing;

    (d) The Seller has the corporate power and authority to enter into this Agreement and the transactions contemplated hereby have been duly authorized by all necessary corporate action of Company;

    (e) This Agreement constitutes a legal, valid and binding obligation of the Seller, enforceable against the Seller in accordance with its terms, except as enforceability may be affected by bankruptcy, insolvency, moratorium or similar laws or by
        legal or equitable principles related to or limiting creditors' rights generally;

    (f) The execution, delivery and performance of this Agreement by the Seller and the consummation of the transactions contemplated hereby will not result in a breach or violation by the Seller of, or constitute a default by the Seller under any
        of Seller’s governing documents or any judgment, decree, order, governmental permit, license, agreement, indenture, instrument, statute, rule or regulation to which the Seller is a party or by which the Seller is bound, in each case, other than any
        breach, violation or default that would not materially impair the ability of the Seller to perform its obligations under this Agreement or to consummate the transactions contemplated hereby, and no authorization, approval or consent, except such as
        have been obtained, is required in connection with the execution, delivery and performance by the Seller of this Agreement or the consummation of the transactions contemplated hereby;

    (g) The Seller has (i) reviewed the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the Securities and Exchange Commission (the "SEC") on February 25, 2021, the Company's Quarterly Reports on
        Form 10-Q for the quarterly period ended March 31, 2021, filed with the SEC on April 28, 2021, the Company's Current Reports on Form 8-K filed with the SEC after December 31, 2020, and the other publicly available filings made by Company with the
        SEC, information and reports furnished by Company, other publicly available information regarding the Company, and such other information that it and its advisers deem necessary and sufficient to make its decision to enter into this Agreement, (ii)
        made Seller's own investigations of the Company, its businesses, personnel, operations and prospects, (iii) had an opportunity to discuss the Company's business, management and financial affairs with officers of the Company and (iv) conducted and
        completed its own independent due diligence with respect to the transactions contemplated by this Agreement;

    (h) Seller (i) has independently made its own analysis and decision to enter into the transactions contemplated by this Agreement, (ii) is relying exclusively on its own investment analysis and due diligence (including such professional advice
        as it deems appropriate) and the representations and warranties by the Company set forth herein with respect to the transactions contemplated by this Agreement, the Shares and the business, condition (financial and otherwise), management,
        operations, properties and prospects of the Company and (iii) hereby waives any claims against the Company with respect to such investigation, analysis and investment decision;

    (i) The Seller acknowledges that the Company may be privy to material non-public information regarding the Company (collectively, the “Non-Public Information”), which may be material to a reasonable investor, such as the Seller, when
        making investment disposition decisions, including the decision to enter into the Agreement, and the Seller’s decision to enter into the Agreement is being made with full recognition and acknowledgment that the Company may be privy to the
        Non-Public Information, irrespective of whether such Non-Public Information has been provided to the Seller. The Seller hereby waives any claim, or potential claim, it has or may have against the Company relating to the Company’s possession of
        Non-Public Information in connection with the matters contemplated by this Agreement and the Company shall not have any liability to the Seller, and the Seller to the fullest extent of the law waives and releases any claims, whether known or
        unknown, that it might have against the Company, whether under applicable securities laws or otherwise, with respect to the  nondisclosure of the Non-Public Information in connection with the purchase of the Shares and the transactions contemplated
        by this Agreement;

    (j) The Seller acknowledges and agrees that the Company is relying on Seller's representations, warranties and agreements herein in proceeding with this Agreement and the transactions contemplated hereby and the Seller agrees to such reliance.
        Without such representations, warranties and agreements, the Company would not enter into this Agreement and the transactions contemplated hereby; and

    (k) The Seller acknowledges that it has not relied upon any express or implied representations or warranties of any nature made by or on behalf of the Company or its subsidiaries, whether or not any such representations, warranties or statements
        were made in writing or orally, except as expressly set forth for the benefit of the Seller in this Agreement.

    4. Representations and Warranties of Company.  The Company represents and warrants to the Seller as of the date hereof and as of the Closing Date as follows:

    (a) The Company is a corporation duly organized, validly existing, and in good standing under the laws of the State of Delaware;

    (b) This Agreement constitutes a legal, valid and binding obligation of Company, enforceable against Company in accordance with its terms, except as enforceability may be affected by bankruptcy, insolvency, fraudulent conveyance, moratorium or
        similar laws or by legal or equitable principles related to or limiting creditors' rights generally;

    (c) The Company has the corporate power and authority to enter into this Agreement and the transactions contemplated hereby have been duly authorized by all necessary corporate action of Company;

    (d) The execution, delivery and performance of this Agreement by the Company and the consummation of the transactions contemplated hereby will not result in a breach or violation by Company of, or constitute a default by the Company under any of
        its governing documents or any judgment, decree, order, governmental permit, license, agreement, indenture, instrument, statute, rule or regulation to which it or any of its subsidiaries is a party or by which it or any of its subsidiaries is bound
        or to which any of its or any of its subsidiaries’ properties or assets is subject, in each case, other than any breach, violation or default that would not materially impair the ability of the Company to perform its obligations under this
        Agreement or to consummate the transactions contemplated hereby, and no authorization, approval or consent, except to the extent obtained, is required in connection with the execution, delivery and performance by the Company of this Agreement or
        the consummation of the transactions contemplated hereby;

    (e) The Company will have as of the Closing Date legally available funds sufficient to consummate the transactions contemplated by this Agreement. After giving effect to the transactions contemplated hereby, the Company will have adequate
        surplus and the transactions contemplated hereby will be in compliance with Section 160 of the Delaware General Corporation Law;

    (f) Both immediately prior to and after giving effect to the transactions contemplated hereby, the Company shall be Solvent (as defined below).  For purposes of this Agreement, the term “Solvent” means that, as of the applicable time of
        determination, the Company and its subsidiaries, taken as a whole, (A) are able to pay their respective debts as they become due; (B) own property which has a fair value greater than the amounts required to pay their respective debts (including a
        reasonable estimate of the amount of all contingent liabilities); and (C) have adequate capital to carry on their respective businesses.  No transfer of property is being made and no obligation is being incurred in connection with the transactions
        contemplated by this Agreement with the intent to hinder, delay or defraud either present or future creditors of the Company or its subsidiaries;

    (g) The Company (i) has independently made its own analysis and decision to enter into the transactions contemplated by this Agreement, (ii) is relying exclusively on its own investment analysis and due diligence (including such professional
        advice as it deems appropriate) and the representations and warranties of the Seller set forth herein with respect to the transactions contemplated by this Agreement, the Shares and the business, condition (financial and otherwise), management,
        operations, properties and prospects of the Company and (iii) hereby waives any claims against the Seller with respect to such investigation, analysis and investment decision;

    (h) The Company acknowledges that the Seller may be privy to material non-public information regarding matters affecting the Company (collectively, the “Seller Non-Public Information”), which may be material to the Company when making
        investment decisions, including the decision to enter into the Agreement, and the Company’s decision to enter into the Agreement is being made with full recognition and acknowledgment that the Seller may be privy to Seller Non-Public Information,
        irrespective of whether such Seller Non-Public Information has been provided to the Company. The Company hereby waives any claim, or potential claim, it has or may have against the Seller relating to the Seller’s possession of Seller Non-Public
        Information in connection with the matters contemplated by this Agreement and the Seller shall not have any liability to the Company, and the Company to the fullest extent of the law waives and releases any claims, whether known or unknown, that it
        might have against the Seller, whether under applicable securities laws or otherwise, with respect to the nondisclosure of the Seller Non-Public Information in connection with the sale of the Shares and the transactions contemplated by this
        Agreement;

    (i) The Company has reviewed such information that it and its advisers deem necessary and sufficient to make its decision to enter into this Agreement, had an opportunity to discuss the Seller Non-Public Information with the Seller and conducted
        and completed its own independent due diligence with respect to the transactions contemplated by this Agreement;

    (j) The Company acknowledges and agrees that the Seller is relying on the Company’s representations, warranties and agreements herein in proceeding with this Agreement and the transactions contemplated hereby and the Company agrees to such
        reliance. Without such representations, warranties and agreements, the Seller would not enter into this Agreement and the transactions contemplated hereby; and

    (k) The Company acknowledges that it has not relied upon any express or implied representations or warranties of any nature made by or on behalf of the Seller or its affiliates, whether or not any such representations, warranties or statements
        were made in writing or orally, except as expressly set forth for the benefit of the Company in this Agreement.

    5. Survival of Representations, Warranties and Covenants.  All representations, warranties and covenants contained herein shall survive the execution of this Agreement and the consummation of the transactions contemplated hereby.

    6. Successors and Assigns.  This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, representatives, successors and assigns.  The Agreement may not be assigned by either party
        without the prior written consent of the other party.  Any assignment purported to be made in violation of the foregoing shall be null and void.

    7. Severability.  In the event that any portion of this Agreement may be held to be invalid or unenforceable for any reason, it is hereby agreed that such invalidity or unenforceability shall not affect the other portions of this
        Agreement and that the remaining covenants, terms and conditions or portions hereof shall remain in full force and effect, and any court of competent jurisdiction may so modify the objectionable provision as to make it valid, reasonable and
        enforceable.

    8. Entire Agreement.  This Agreement contains the complete agreement among the parties hereto with respect to the transactions contemplated hereby and supersedes all prior agreements and understandings among the parties hereto with
        respect to such transactions.

    9. Governing Law.  This Agreement and any proceeding, dispute or controversy (a “Proceeding”) or other matter relating hereto or thereto (or the negotiation hereof) shall be construed and enforced in accordance with the laws of
        the State of Delaware without giving effect to any conflicts of law rules or provisions that would compel the application of the substantive laws of another jurisdiction.

    10. Venue. All Proceedings arising out of or relating to this Agreement (or the negotiation hereof) shall be heard and determined exclusively in the Delaware Court of Chancery and the appellate courts therefrom or, solely to the extent
        such courts lack jurisdiction, any federal court sitting in the State of Delaware and any appellate courts therefrom.  Consistent with the preceding sentence, the parties hereto hereby (a) submit to the exclusive jurisdiction of such courts for the
        purpose of any such Proceeding brought by any party hereto and (b) irrevocably waive, and agree not to assert by way of motion, defense, or otherwise, in any such Proceeding, any claim that it is not subject personally to the jurisdiction of the
        above named courts, that its property is exempt or immune from attachment or execution, that the Proceeding is brought in an inconvenient forum, that the venue of the Proceeding is improper, or that this Agreement or the transactions contemplated
        by this Agreement may not be enforced in or by any of the above named courts.

    11. Specific Performance. The parties hereby agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that any provision of this Agreement (including failing to
        take such actions as are required of any party hereunder to consummate the transactions contemplated hereby) is not performed in accordance with its specific terms or is otherwise breached.  Accordingly, the parties agree that each party shall be
        entitled to an injunction or injunctions, or any other appropriate form of specific performance or equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof and thereof in any court of
        competent jurisdiction in accordance with Section 10, this being in addition to any other remedy to which they are entitled under the terms of this Agreement, at law, in equity or otherwise, and each party hereby waives any requirement for
        the securing or posting of any bond or other collateral in connection with such remedy or any right to object to any such remedy.

    12. Waiver of Jury Trial.  Each of the parties hereto hereby waives to the fullest extent permitted by applicable law any right it may have to a trial by jury with respect to any litigation directly or indirectly arising out of, under or
        in connection with this Agreement or the transactions contemplated by this Agreement.

    13. Further Assurances.  Each of the parties hereto shall take, or cause to be taken, all appropriate action, to do or cause to be done all things necessary, proper or advisable under applicable law, and to execute and deliver such
        documents and other papers, as may be required to carry out the provisions of this Agreement and to consummate and make effective the transaction contemplated by this Agreement.

    14. Public Announcements.  The parties agree that (i) the initial press release by the Seller, the initial press release by the Company, and the SEC filing on Form 8-K by the Company, each disclosing the execution and delivery of this
        Agreement and the transactions contemplated hereby and the SEC filing on Form 8-K by the Company disclosing the results of the Company’s annual meeting shall be in the forms attached hereto as Exhibits A-D (the “Agreed Disclosures”). 

        Each of the parties agrees that, other than the Agreed Disclosures or as permitted by the immediately succeeding sentence, and except as may be required by law, rule, regulation or the requirements of any self-regulatory organization or stock
        exchange listing requirements (in which case the party required to make the filing, disclosure, communication, release or announcement shall allow the other party reasonable time to comment thereon in advance of such statement, release, filing,
        disclosure, communication or announcement and will consider in good faith any comments provided by such party), each of the parties hereto will not make any public statement, press release or other public filing, disclosure, communication, release,
        or announcement with respect to this Agreement and any of the transactions contemplated by this Agreement, including the circumstances or discussions (to the extent related to the Seller’s relationship with the Company as a stockholder of the
        Company and not, for clarity, in connection with the Commercial Agreements (as defined below)) in the twelve months leading to the negotiation and execution of this Agreement (or substantially the same circumstances or discussions prior thereto);
        provided, that nothing herein shall limit or prevent a party from making any statements, press releases or other filings, disclosures, communications, releases or announcements to the extent reasonably related to such party exercising or enforcing
        any of its rights under this Agreement.  Notwithstanding the foregoing, each of the parties shall be entitled to make public statements or disclosures that are substantially consistent with the Agreed Disclosures; provided, that Seller shall
        provide the Company with a reasonable time to review and comment on the amendment to Schedule 13D of the Seller (or its affiliates).

    15. Fees and Expenses.  All costs and expenses incurred in connection with this Agreement and the transaction contemplated by this Agreement shall be the responsibility of and shall be paid by the party incurring such fees or expenses,
        whether or not the transaction contemplated by this Agreement is consummated.

    16. Entire Agreement.  This Agreement contains the entire agreement and understanding between the parties with respect to the subject matter hereof and supersede all prior agreements and understandings relating to such subject matter. 
        For the avoidance of doubt, nothing herein shall limit or amend the rights or obligations of any party or any of their affiliates (including the right to receive royalties) under that certain Collaboration Agreement, dated as of November 14, 2002
        or that certain Strategic Alliance Agreement, dated as of March 30, 2004, each as amended from time to time, and any related agreements or instruments (collectively, the “Commercial Agreements”).

     
    17. Amendments; Waiver.  No amendment to this Agreement shall be effective unless it shall be in writing and signed by all parties.  No waiver of any term, provision or condition of this Agreement will be effective unless memorialized in
        writing and signed by the party against whom such waiver is to be enforced; and no waiver of any breach of this Agreement will be implied from any forbearance or failure of a party to take action thereon.

    18. Pre-Closing Rights.  Nothing contained in this Agreement shall in anyway alter, limit or impair or be interpreted to alter, limit or impair the rights, privileges or obligations of the Seller with respect to the Seller’s ownership of
        the Shares prior to the Closing, including the right of the Seller to, prior to the Closing, receive any dividends payable on the Shares prior to the Closing or vote the Shares with respect to any matters submitted for a stockholder vote prior to
        the Closing.

    19. Counterparts.  This Agreement may be executed by facsimile or electronic signature and in two or more counterparts, each of which shall be deemed an original but all of which shall constitute but one instrument.

    [Remainder of page intentionally left blank. Signature page follows.]

    
      
        

    

    

    

    IN WITNESS WHEREOF, the parties thereto have executed this Agreement as of the date first above written.

    COMPANY

    

    

    INNOVIVA, INC.

    

    

    

    

    By:  /s/ Pavel Raifeld                                           

      

    Name: Pavel Raifeld

    Title:  Chief Executive Officer

    
      
        

    

    

    

    SELLER:

    

    

    GLAXO GROUP LIMITED

    

    

    

    

    By: /s/ Peter Hopkins_____________________

    Name: Peter Hopkins

    

    Title: Authorized Signatory by Power of Attorney

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]